Stock listing
Cboe Canada:NTLX NeuroThera Labs Inc. Stock
Canadian listing (Cboe Canada) of NeuroThera Labs Inc. · home listing TSXV:NTLX
Follow NeuroThera Labs Inc. into a list and get an email when it puts out news.
Home listing price · TSXV:NTLX
$1.62 CAD +0.01 (+0.6%)
Close on Oct 27, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:NTLX
- Day range
- $1.62 – $1.62 CADOct 27, 2026
- Volume
- 714 sharesOct 27, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- 52-week range
- $1.61 – $5.32 CADLowest and highest trades, Oct 28, 2025 – Oct 27, 2026
- Traded on an average day
- $487 CADMedian day 0 shares · 40 days with no trades · last 3 months, Jul 27, 2026 – Oct 27, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:NTLX · Home | $1.62 CAD | +0.01 (+0.6%) | 714 | $1.62 | $1.62 | $1.62 | $1.61 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 27, 2026 – Oct 27, 2026 · TSXV:NTLX · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.62 | +0.01 | +0.6% | $1.62 | $1.62 | $1.62 | 714 | |
| $1.61 | -0.05 | -3.0% | $1.61 | $1.61 | $1.61 | 328 | |
| $1.66 | 0.00 | 0.0% | $1.66 | $1.66 | $1.66 | 0 | |
| $1.66 | -0.01 | -0.6% | $1.66 | $1.66 | $1.66 | 101 | |
| $1.67 | 0.00 | 0.0% | $1.67 | $1.67 | $1.67 | 0 | |
| $1.67 | -0.63 | -27.4% | $1.67 | $1.67 | $1.67 | 357 | |
| $2.30 | 0.00 | 0.0% | $2.30 | $2.30 | $2.30 | 0 | |
| $2.30 | 0.00 | 0.0% | $2.30 | $2.30 | $2.30 | 0 | |
| $2.30 | 0.00 | 0.0% | $2.30 | $2.30 | $2.30 | 0 | |
| $2.30 | 0.00 | 0.0% | $2.30 | $2.30 | $2.30 | 0 | |
| $2.30 | -2.10 | -47.7% | $2.30 | $2.30 | $2.30 | 100 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.30 | $4.40 | $4.30 | 209 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 193 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | 0.00 | 0.0% | $4.40 | $4.40 | $4.40 | 0 | |
| $4.40 | +0.01 | +0.2% | $4.40 | $4.40 | $4.40 | 219 | |
| $4.39 | 0.00 | 0.0% | $4.39 | $4.39 | $4.39 | 0 | |
| $4.39 | 0.00 | 0.0% | $4.39 | $4.39 | $4.39 | 0 | |
| $4.39 | +1.03 | +30.7% | $4.40 | $4.40 | $4.00 | 982 | |
| $3.36 | 0.00 | 0.0% | $3.36 | $3.36 | $3.36 | 0 | |
| $3.36 | 0.00 | 0.0% | $3.36 | $3.36 | $3.36 | 0 | |
| $3.36 | 0.00 | 0.0% | $3.36 | $3.36 | $3.36 | 0 | |
| $3.36 | 0.00 | 0.0% | $3.36 | $3.36 | $3.36 | 0 | |
| $3.36 | -0.91 | -21.3% | $3.22 | $3.36 | $3.22 | 122 | |
| $4.27 | -1.05 | -19.7% | $4.27 | $4.27 | $4.27 | 31 | |
| $5.32 | 0.00 | 0.0% | $5.32 | $5.32 | $5.32 | 0 | |
| $5.32 | 0.00 | 0.0% | $5.32 | $5.32 | $5.32 | 0 | |
| $5.32 | 0.00 | 0.0% | $5.32 | $5.32 | $5.32 | 0 | |
| $5.32 | +0.49 | +10.1% | $4.83 | $5.32 | $4.83 | 388 | |
| $4.83 | 0.00 | 0.0% | $4.83 | $4.83 | $4.83 | 0 | |
| $4.83 | 0.00 | 0.0% | $4.83 | $4.83 | $4.83 | 0 | |
| $4.83 | -0.07 | -1.4% | $4.83 | $4.83 | $4.83 | 5 | |
| $4.90 | 0.00 | 0.0% | $4.90 | $4.90 | $4.90 | 0 | |
| $4.90 | 0.00 | 0.0% | $4.90 | $4.90 | $4.90 | 0 | |
| $4.90 | +0.35 | +7.7% | $4.48 | $4.90 | $4.48 | 380 | |
| $4.55 | 0.00 | 0.0% | $4.55 | $4.55 | $4.55 | 0 | |
| $4.55 | 0.00 | 0.0% | $4.55 | $4.55 | $4.55 | 0 | |
| $4.55 | 0.00 | 0.0% | $4.55 | $4.55 | $4.55 | 0 | |
| $4.55 | +0.49 | +12.1% | $4.20 | $4.55 | $4.20 | 520 | |
| $4.06 | 0.00 | 0.0% | $4.06 | $4.06 | $4.06 | 0 | |
| $4.06 | +0.63 | +18.4% | $3.22 | $4.06 | $3.22 | 286 | |
| $3.43 | +0.35 | +11.4% | $3.43 | $3.43 | $3.43 | 128 | |
| $3.08 | 0.00 | 0.0% | $3.08 | $3.08 | $3.08 | 0 | |
| $3.08 | 0.00 | 0.0% | $3.08 | $3.08 | $3.08 | 0 | |
| $3.08 | -0.28 | -8.3% | $3.08 | $3.08 | $3.08 | 102 | |
| $3.36 | +0.14 | +4.3% | $3.29 | $3.36 | $3.29 | 166 | |
| $3.22 | +0.42 | +15.0% | $2.80 | $3.22 | $2.80 | 622 | |
| $2.80 | 0.00 | 0.0% | $2.80 | $2.80 | $2.80 | 2,980 | |
| $2.80 | +0.42 | +17.6% | $2.80 | $2.80 | $2.80 | 291 |
- Ticker
- Cboe Canada:NTLX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Cboe Canada
- Currency
- CAD
What changed lately
Latest news release · Oct 22, 2026
NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome
Latest news
NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome
Oct 22, 2026
Closed $1.61 (-3.0%) on Oct 22, 2026
NeuroThera Labs' CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company's Quantum Architecture
Oct 7, 2026
Closed $4.40 (0.0%) on Oct 7, 2026
NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
Sep 23, 2026
Closed $4.40 (0.0%) on Sep 23, 2026
NeuroThera Labs Achieves Significant Enrollment Momentum in SCI210 Autism Clinical Trial
Aug 31, 2026
Closed $3.36 (-21.3%) on Sep 1, 2026
Neurothera Labs Inc. Announces Share Consolidation
Aug 28, 2026
Closed $4.27 (-19.7%) on Aug 31, 2026
NeuroThera Labs Engages Dr. Reuter Investor Relations
Aug 27, 2026
Closed $5.32 (0.0%) on Aug 27, 2026
NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Aug 24, 2026
Closed $4.83 (0.0%) on Aug 24, 2026
Neurothera Labs Inc. Closes Final Tranche of Non-Brokered Private Placement
Aug 17, 2026
Closed $4.90 (0.0%) on Aug 18, 2026
NeuroThera Labs Inc. Closes First Tranche of Non-Brokered Private Placement
Aug 12, 2026
Closed $4.55 (0.0%) on Aug 13, 2026
NeuroThera Labs Granted Japanese Patent for Its Proprietary, Innovative Therapeutic Combination
Aug 12, 2026
Closed $4.55 (0.0%) on Aug 12, 2026
Financings
Private placement of units
Aug 18, 2026
Closed: C$2.7M in the latest tranche · C$0.12 a unit · 1 warrant at US$0.115
Buyers: SciSparc Ltd. (22,500,000 Units for an aggregate subscription price of C$2,700,000)
Insiders: SciSparc Ltd., a control person, subscribed for 22,500,000 Units for C$2,700,000; a related party transaction under MI 61-101
Use of proceeds: General working capital and other corporate and administrative expenses
NeuroThera Labs Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 33 in the last 12 months · 34 in all · newest Oct 22, 2026 · oldest 2025
Where NeuroThera Labs Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:NTLX · Home listing | TSXV | Canada | CAD |
| Frankfurt:C0A | Frankfurt | Germany | EUR |
| Cboe Canada:NTLX · This page | Cboe Canada | Canada | CAD |
Log in to ask 6ix AI your own questions about NeuroThera Labs Inc.